• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

世界卫生组织、全球疾病负担和全球癌症观察站原发性肝癌死亡率估计数的比较。

Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory.

机构信息

Melbourne School of Population & Global Health, The University of Melbourne, Melbourne, Australia.

School of Population Health, UNSW Sydney, Sydney, Australia.

出版信息

Liver Int. 2022 Oct;42(10):2299-2316. doi: 10.1111/liv.15357. Epub 2022 Jul 9.

DOI:10.1111/liv.15357
PMID:35779247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9543750/
Abstract

AIMS

This study aims to compare estimates of primary liver cancer mortality from World Health Organization (WHO), Global Burden Disease (GBD) and Global Cancer Observatory (GCO).

METHODS

Liver cancer mortality was extracted from WHO, GBD and GCO for 92 countries for the most recent year. Age-standardized rate (ASR) was computed and used for current comparisons across the three data sources. Temporal trend for 75 countries was analysed and compared between WHO and GBD from 1990 to 2019 using joinpoint regression. Average annual percentage change for the most recent 10 years was used as indicator for change.

RESULTS

The estimates of ASR were quite consistent across the three data sources, but most similar estimates were found between WHO and GCO in both region and country levels. The differences in ASR were negatively correlated with completeness of cause-of-death registration, human development index and proportion of liver cancer because of alcohol consumption. Consistent trends of ASR were found from 35 countries between WHO and GBD in the most recent 10 years. However, opposite trends were found from 10 countries with five from Southern America, four from Europe and one from Asia. Of the 18 countries for projection, opposite trends between WHO and GBD were found from seven countries.

CONCLUSION

While the ASR of primary liver cancer mortality was comparable across the three data sources, most similar estimates were found between WHO and GCO. The opposite trends found from 10 countries between WHO and GBD raised concerns of true patterns in these countries.

摘要

目的

本研究旨在比较世界卫生组织(WHO)、全球疾病负担(GBD)和全球癌症观测站(GCO)对原发性肝癌死亡率的估计。

方法

从 WHO、GBD 和 GCO 中提取了 92 个国家最近一年的肝癌死亡率数据。计算了年龄标准化率(ASR),并用于当前在这三个数据源之间进行比较。分析了 75 个国家的时间趋势,并使用 joinpoint 回归比较了 1990 年至 2019 年 WHO 和 GBD 之间的趋势。使用最近 10 年的平均年变化百分比作为变化的指标。

结果

三个数据源的 ASR 估计值相当一致,但在区域和国家层面,WHO 和 GCO 的估计值最为相似。ASR 的差异与死因登记完整性、人类发展指数和因酒精消费导致的肝癌比例呈负相关。在最近 10 年,WHO 和 GBD 在 35 个国家之间发现了 ASR 的一致趋势。然而,在 10 个国家中发现了相反的趋势,其中 5 个来自南美洲,4 个来自欧洲,1 个来自亚洲。在 18 个预测国家中,WHO 和 GBD 之间发现了 7 个国家的趋势相反。

结论

尽管原发性肝癌死亡率的 ASR 在三个数据源之间具有可比性,但 WHO 和 GCO 之间的估计值最为相似。WHO 和 GBD 在 10 个国家之间发现的相反趋势引起了对这些国家真实模式的关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/9543750/d145a55b3498/LIV-42-2299-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/9543750/9061557ff1c9/LIV-42-2299-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/9543750/8374262165cb/LIV-42-2299-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/9543750/f59ca17f7f03/LIV-42-2299-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/9543750/855f811a22cb/LIV-42-2299-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/9543750/d145a55b3498/LIV-42-2299-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/9543750/9061557ff1c9/LIV-42-2299-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/9543750/8374262165cb/LIV-42-2299-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/9543750/f59ca17f7f03/LIV-42-2299-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/9543750/855f811a22cb/LIV-42-2299-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4f/9543750/d145a55b3498/LIV-42-2299-g005.jpg

相似文献

1
Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory.世界卫生组织、全球疾病负担和全球癌症观察站原发性肝癌死亡率估计数的比较。
Liver Int. 2022 Oct;42(10):2299-2316. doi: 10.1111/liv.15357. Epub 2022 Jul 9.
2
What is the true tuberculosis mortality burden? Differences in estimates by the World Health Organization and the Global Burden of Disease study.真实的结核病死亡负担是多少?世界卫生组织和全球疾病负担研究的估计值存在差异。
Int J Epidemiol. 2018 Oct 1;47(5):1549-1560. doi: 10.1093/ije/dyy144.
3
Differences in the incidence and mortality of digestive cancer between Global Cancer Observatory 2020 and Global Burden of Disease 2019.全球癌症观察站 2020 年与全球疾病负担 2019 年消化系统癌症发病率和死亡率的差异。
Int J Cancer. 2024 Feb 15;154(4):615-625. doi: 10.1002/ijc.34740. Epub 2023 Sep 26.
4
Global, regional and national burden of primary liver cancer by subtype.全球、区域和国家原发性肝癌的亚型负担。
Eur J Cancer. 2022 Jan;161:108-118. doi: 10.1016/j.ejca.2021.11.023. Epub 2021 Dec 20.
5
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends.多发性骨髓瘤的流行病学概况:全球癌症登记处对疾病负担、风险因素和时间趋势的估计。
Lancet Haematol. 2022 Sep;9(9):e670-e677. doi: 10.1016/S2352-3026(22)00165-X. Epub 2022 Jul 14.
6
The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.特定病因引起的原发性肝癌发病率趋势:2016 年全球疾病负担研究结果及其对肝癌预防的意义。
J Hepatol. 2019 Apr;70(4):674-683. doi: 10.1016/j.jhep.2018.12.001. Epub 2018 Dec 11.
7
Disease Burden, Risk Factors, and Recent Trends of Liver Cancer: A Global Country-Level Analysis.肝癌的疾病负担、风险因素及近期趋势:一项全球国家层面分析
Liver Cancer. 2021 Jul;10(4):330-345. doi: 10.1159/000515304. Epub 2021 Mar 30.
8
Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer.全球胰腺癌负担、风险因素及趋势。
Gastroenterology. 2021 Feb;160(3):744-754. doi: 10.1053/j.gastro.2020.10.007. Epub 2020 Oct 13.
9
Comparing road safety performance across countries: Do data source and type of mortality indicator matter?比较不同国家的道路安全绩效:数据来源和死亡率指标类型是否重要?
Accid Anal Prev. 2018 Dec;121:129-133. doi: 10.1016/j.aap.2018.09.012. Epub 2018 Sep 20.
10
The burden of liver cirrhosis in mortality: Results from the global burden of disease study.肝硬化在死亡率中的负担:来自全球疾病负担研究的结果。
Front Public Health. 2022 Aug 11;10:909455. doi: 10.3389/fpubh.2022.909455. eCollection 2022.

引用本文的文献

1
Differences in the incidence and mortality of tracheal, bronchus, and lung cancer between the Global Cancer Observatory 2022 and the Global Burden of Disease 2021.全球癌症观测站2022年与全球疾病负担2021年中气管、支气管和肺癌发病率及死亡率的差异。
J Natl Cancer Cent. 2025 Feb 27;5(3):267-277. doi: 10.1016/j.jncc.2025.02.004. eCollection 2025 Jun.
2
Epidemiological and demographic analysis of liver cancer attributable to modifiable risk factors from 1990 to 2021.1990年至2021年可改变风险因素所致肝癌的流行病学和人口统计学分析
Sci Rep. 2025 Jun 1;15(1):19217. doi: 10.1038/s41598-025-02031-w.
3
Colorectal Cancer: Risk Factors, Novel Approaches in Molecular Screening and Treatment.

本文引用的文献

1
The impact of hepatitis B vaccination in the United States, 1999-2018.1999-2018 年美国乙型肝炎疫苗接种的影响。
Hepatology. 2022 Jun;75(6):1566-1578. doi: 10.1002/hep.32265. Epub 2021 Dec 19.
2
Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends.最近全球宫颈癌发病率和死亡率、预测因素以及时间趋势。
Gynecol Oncol. 2021 Dec;163(3):583-592. doi: 10.1016/j.ygyno.2021.10.075. Epub 2021 Oct 20.
3
Contrasting Trends of Primary Liver Cancer Mortality in Chinese Mongol and Non-Mongol.
结直肠癌:风险因素、分子筛查与治疗的新方法
Int J Mol Cell Med. 2025;14(1):576-605. doi: 10.22088/IJMCM.BUMS.14.1.576.
4
The coping experiences in patients with hepatocellular carcinoma and their spouses following postoperative recurrence: A dyadic qualitative study.肝细胞癌患者及其配偶术后复发后的应对经历:一项二元定性研究。
Asia Pac J Oncol Nurs. 2025 Feb 11;12:100665. doi: 10.1016/j.apjon.2025.100665. eCollection 2025 Dec.
5
Clinical value of systemic immunoinflammatory index in predicting recurrence and metastasis in patients with primary liver cancer.全身免疫炎症指数在预测原发性肝癌患者复发和转移中的临床价值
BMC Gastroenterol. 2025 Mar 13;25(1):169. doi: 10.1186/s12876-025-03749-7.
6
Bioactive Secondary Metabolites from Linn. Roots: Isolation, Characterization, and Cytotoxic Evaluation.来自[植物名称] Linn. 根的生物活性次生代谢产物:分离、表征及细胞毒性评价。 (由于“Linn.”前面的植物名称未给出,这里翻译不太完整,需根据具体植物名补充完整)
Curr Pharm Des. 2025;31(15):1239-1246. doi: 10.2174/0113816128299481240223054918.
7
Exploring oral candidiasis among cancer patients undergoing chemotherapy in eastern Iran.探索伊朗东部接受化疗的癌症患者中的口腔念珠菌病。
Iran J Microbiol. 2024 Dec;16(6):803-811. doi: 10.18502/ijm.v16i6.17259.
8
Changing global epidemiology of chronic hepatitis C virus-related outcomes from 2010 to 2019: cirrhosis is the growing burden of hepatitis C virus-related disease.2010 年至 2019 年慢性丙型肝炎病毒相关结局的全球流行病学变化:肝硬化是丙型肝炎病毒相关疾病负担日益增加的原因。
Eur J Cancer Prev. 2024 Nov 1;33(6):512-524. doi: 10.1097/CEJ.0000000000000885. Epub 2024 Mar 22.
9
Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019.全球 1990 年至 2019 年因特定病因导致的肝硬化和其他慢性肝病负担。
BMC Public Health. 2024 Feb 3;24(1):363. doi: 10.1186/s12889-024-17948-6.
10
Design, Synthesis, In Vitro, and In Silico Studies of New -Substituted-pyrazolo[3,4-]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors.新型取代吡唑并[3,4 - ]嘧啶酮衍生物作为抗癌CDK2抑制剂的设计、合成、体外及计算机模拟研究
Pharmaceuticals (Basel). 2023 Nov 11;16(11):1593. doi: 10.3390/ph16111593.
中国蒙古族与非蒙古族原发性肝癌死亡率的对比趋势
Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2757-2763. doi: 10.31557/APJCP.2021.22.9.2757.
4
The impact of universal hepatitis B vaccine on the trend of liver cancer from the Global Burden of Disease Study 2017.2017 年全球疾病负担研究:乙型肝炎疫苗普及对肝癌发病趋势的影响。
Liver Int. 2021 Aug;41(8):1762-1774. doi: 10.1111/liv.14821. Epub 2021 Feb 28.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study.全球基于病因的原发性肝癌发病率趋势:1990 年至 2030 年的建模研究。
Int J Epidemiol. 2021 Mar 3;50(1):128-142. doi: 10.1093/ije/dyaa196.
7
The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017.1990年至2017年全球、区域、国家、年龄和性别层面特定病因所致原发性肝癌的负担及趋势:全球疾病负担研究2017结果
Liver Cancer. 2020 Sep;9(5):563-582. doi: 10.1159/000508568. Epub 2020 Jul 23.
8
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
9
History of global burden of disease assessment at the World Health Organization.世界卫生组织全球疾病负担评估的历史。
Arch Public Health. 2020 Aug 24;78:77. doi: 10.1186/s13690-020-00458-3. eCollection 2020.
10
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.2012 年至 2017 年全球慢性肝病负担的变化:非酒精性脂肪性肝病的影响日益增加。
Hepatology. 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27.